Categories AlphaGraphs, Consumer, Earnings

Conagra Brands falls despite beating Q2 earnings, misses on sales

Conagra Brands (CAG) reported second quarter 2019 results and fell more than 5% during the extended trading hours, hurt by the sales miss and weak outlook. The packaged food company’s GAAP EPS from continuing operations decreased to $0.32 from $0.54 in the prior year quarter, and adjusted EPS from continuing operations grew 22% to $0.67 from $0.55 a year ago. Wall Street expected Conagra to post earnings of $0.56 per share.

Conagra Brands (CAG) Q2 2019 earnings infograph

Total sales grew 9.7% year-over-year to $2.38 billion, driven by Pinnacle acquisition. Sales missed the analysts’ estimates of $2.41 billion. Sales from Refrigerated & Frozen segment increased 1.7%, while sales from Grocery & Snacks, International and Food Service segments fell 0.1%, 5.4%, and 16.5%, respectively.

For the 31 days between the Pinnacle acquisition closing date and the Q2 end, net sales for the Pinnacle segment totaled $259 million. Net sales of Pinnacle were below expectations due to weak performance across a range of significant brands, as well as the impact of a product recall on Duncan Hines.

The Chicago-based firm, which completed the Pinnacle Foods acquisition on October 26, reaffirmed legacy Conagra outlook and updated total Conagra guidance for FY19. Legacy Conagra sales are expected to grow in the range of 0.5% to 1.5% and total Conagra sales are estimated to grow in the range of 22% to 23%. Total Conagra adjusted EPS from continuing ops is estimated to be $2.03 to $2.08.

Conagra shares crash after company misses estimates, guides lower

Conagra Brands expects to exceed Pinnacle-related cost synergy target of $215 million by the end of FY22. On a percentage basis, Conagra Brands expects the Pinnacle transaction to be low single-digit accretive to adjusted EPS in the fiscal year ended May 2020 and high single-digit accretive to adjusted EPS in the fiscal year ended May 2022.

Shares of Conagra have fallen 21% in the last three months and 23% in the past one year. The stock, which plunged to a fresh yearly low ($28.41) on Tuesday, ended Wednesday’s trading session by increasing 1.86% at $29.09.

 

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top